Abstract
Arabinomannan (AMannan) and mannan (Mannan) are major polysaccharides antigens of the mycobacterial capsule. They are highly related to the lipoarabinomannan (LAM) and lipomannan (LM) lipoglycans of the cell wall, known to participate to the immunopathogenesis of mycobacterial infections. Here we present the identification of two related polysaccharides from Mycobacterium kansasii that co-purified with AMannan and Mannan. Structural analysis using GC, MALDI-MS and NMR clearly established these molecules as non-acylated phosphorylated AMannan and Mannan designated P-AMannan and P-Mannan, respectively. These glycoconjugates represent a new source of polysaccharide structural variability in mycobacteria and constitute unique tools for structure-activity relationship studies in order to investigate the role of fatty acids in the biological functions of LAM and LM. The potential participation of these polysaccharides in influencing the outcome of the infection is also discussed.
Similar content being viewed by others
Abbreviations
- Ara:
-
arabinose
- ConA:
-
concanavalin A
- GC:
-
gas-chromatography
- HPAEC:
-
high pH anion exchange chromatography
- Ins:
-
inositol
- MALDI-TOF:
-
matrix assisted lazer desorption ionisation coupled to time of flight analyser
- Man:
-
mannose
- Man-ol:
-
mannitol
- Me-Glc:
-
methyl glucoside
- NMR:
-
nuclear magnetic resonance
- TFA:
-
trifluoroacetic acid
- TLC:
-
thin layer chromatography
References
Daffe, M., Draper, P.: The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39, 131–203 (1998)
Lemassu, A., Daffe, M.: Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem. J. 297, 351–357 (1994)
Glatman-Freedman, A., Casadevall, A.: Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11, 514–532 (1998)
Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J.B., Unanue, E., Casadevall, A., Bloom, B.R.: A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc. Natl. Acad. Sci. U. S. A. 95, 15688–15693 (1998)
Ellner, J.J., Daniel, T.M.: Immunosuppression by mycobacterial arabinomannan. Clin. Exp. Immunol. 35, 250–257 (1979)
Briken, V., Porcelli, S.A., Besra, G.S., Kremer, L.: Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53, 391–403 (2004)
Fratti, R.A., Chua, J., Vergne, I., Deretic, V.: Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. U. S. A. 100, 5437–5442 (2003)
Nigou, J., Zelle-Rieser, C., Gilleron, M., Thurnher, M., Puzo, G.: Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166, 7477–7485 (2001)
Vignal, C., Guerardel, Y., Kremer, L., Masson, M., Legrand, D., Mazurier, J., Elass, E.: Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. J. Immunol. 171, 2014–2023 (2003)
Quesniaux, V.J., Nicolle, D.M., Torres, D., Kremer, L., Guerardel, Y., Nigou, J., Puzo, G., Erard, F., Ryffel, B.: Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J. Immunol. 172, 4425–4434 (2004)
Gilleron, M., Nigou, J., Nicolle, D., Quesniaux, V., Puzo, G.: The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2. Chem. Biol. 13, 39–47 (2006)
Elass, E., Aubry, L., Masson, M., Denys, A., Guerardel, Y., Maes, E., Legrand, D., Mazurier, J., Kremer, L.: Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism. Infect. Immun. 73, 7064–7068 (2005)
Guerardel, Y., Maes, E., Briken, V., Chirat, F., Leroy, Y., Locht, C., Strecker, G., Kremer, L.: Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. J. Biol. Chem. 278, 36637–36651 (2003)
Campo, R.E., Campo, C.E.: Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24, 1233–1238 (1997)
Evans, S.A., Colville, A., Evans, A.J., Crisp, A.J., Johnston, I.D.: Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 51, 1248–1252 (1996)
Horsburgh, C.R. Jr., Selik, R.M.: The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir. Dis. 139, 4–7 (1989)
Ehlers, M.R., Daffe, M.: Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol. 6, 328–335 (1998)
Kamerling, J.P., Gerwig, G.J., Vliegenthart, J.F., Clamp, J.R.: Characterization by gas–liquid chromatography-mass spectrometry and proton-magnetic-resonance spectroscopy of pertrimethylsilyl methyl glycosides obtained in the methanolysis of glycoproteins and glycopeptides. Biochem. J. 151, 491–495 (1975)
Lo-Guidice, J.M., Wieruszeski, J.M., Lemoine, J., Verbert, A., Roussel, P., Lamblin, G.: Sialylation and sulfation of the carbohydrate chains in respiratory mucins from a patient with cystic fibrosis. J. Biol. Chem. 269, 18794–18813 (1994)
Ortalo-Magne, A., Lemassu, A., Laneelle, M.A., Bardou, F., Silve, G., Gounon, P., Marchal, G., Daffe, M.: Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 178, 456–461 (1996)
Nigou, J., Gilleron, M., Brando, T., Vercellone, A., Puzo, G.: Structural definition of arabinomannans from Mycobacterium bovis BCG. Glycoconj. J. 16, 257–264 (1999)
Treumann, A., Xidong, F., McDonnell, L., Derrick, P.J., Ashcroft, A.E., Chatterjee, D., Homans, S.W.: 5-Methylthiopentose: a new substituent on lipoarabinomannan in Mycobacterium tuberculosis. J. Mol. Biol. 316, 89–100 (2002)
Turnbull, W.B., Shimizu, K.H., Chatterjee, D., Homans, S.W., Treumann, A.: Identification of the 5-methylthiopentosyl substituent in Mycobacterium tuberculosis lipoarabinomannan. Angew. Chem. Int. Ed. Engl. 43, 3918–3922 (2004)
Joe, M., Sun, D., Taha, H., Completo, G.C., Croudace, J.E., Lammas, D.A., Besra, G.S., Lowary, T.L.: The 5-deoxy-5-methylthio-xylofuranose residue in mycobacterial lipoarabinomannan. Absolute stereochemistry, linkage position, conformation, and immunomodulatory activity. J. Am. Chem. Soc. 128, 5059–5072 (2006)
Guerardel, Y., Maes, E., Elass, E., Leroy, Y., Timmerman, P., Besra, G.S., Locht, C., Strecker, G., Kremer, L.: Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains. J. Biol. Chem. 277, 30635–30648 (2002)
Glatman-Freedman, A., Casadevall, A., Dai, Z., Jacobs, W.R. Jr., Li, A., Morris, S.L., Navoa, J.A., Piperdi, S., Robbins, J.B., Schneerson, R., Schwebach, J.R., Shapiro, M.: Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. J. Clin. Microbiol. 42, 3225–3231 (2004)
Navoa, J.A., Laal, S., Pirofski, L.A., McLean, G.R., Dai, Z., Robbins, J.B., Schneerson, R., Casadevall, A., Glatman-Freedman, A.: Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. Clin. Diagn. Lab. Immunol. 10, 88–94 (2003)
Stokes, R.W., Doxsee, D.: The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages. Cell. Immunol. 197, 1–9 (1999)
Venisse, A., Fournie, J.J., Puzo, G.: Mannosylated lipoarabinomannan interacts with phagocytes. Eur. J. Biochem. 231, 440–447 (1995)
Sieling, P.A., Chatterjee, D., Porcelli, S.A., Prigozy, T.I., Mazzaccaro, R.J., Soriano, T., Bloom, B.R., Brenner, M.B., Kronenberg, M., Brennan, P.J., et al.: CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227–230 (1995)
Nigou, J., Gilleron, M., Cahuzac, B., Bounery, J.D., Herold, M., Thurnher, M., Puzo, G.: The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guerin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J. Biol. Chem. 272, 23094–23103 (1997)
Barnes, P.F., Chatterjee, D., Abrams, J.S., Lu, S., Wang, E., Yamamura, M., Brennan, P.J., Modlin, R.L.: Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J. Immunol. 149, 541–547 (1992)
Sidobre, S., Nigou, J., Puzo, G., Riviere, M.: Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to mycobacteria. Critical role of the lipids for lectin-carbohydrate recognition. J. Biol. Chem. 275, 2415–2422 (2000)
Elass, E., Coddeville, B., Guerardel, Y., Kremer, L., Maes, E., Mazurier, J., Legrand, D.: Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS-binding protein. FEBS Lett. 581, 1383–1390 (2007)
Acknowledgments
This study was funded by a grant from the french National Research Agency (ANR-05-MIIM-025). LK is supported by a grant from the Centre National de la Recherche Scientifique (CNRS) (Action Thématique Incitative sur Programme “Microbiologie Fondamentale”).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maes, E., Coddeville, B., Kremer, L. et al. Polysaccharide structural variability in mycobacteria: identification and characterization of phosphorylated mannan and arabinomannan. Glycoconj J 24, 439–448 (2007). https://doi.org/10.1007/s10719-007-9036-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-007-9036-1